Picture of Image Scan Holdings logo

IGE Image Scan Holdings News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

REG - Image Scan Holdings - Final Results

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251202:nRSB7699Ja&default-theme=true

RNS Number : 7699J  Image Scan Holdings PLC  02 December 2025

 

 IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

 

Final Results for the Year Ended 30 September 2025

 

Image Scan (AIM: IGE), the specialist supplier of X-ray screening systems to
the security and industrial inspection markets, today announces final results
for the year ended 30 September 2025.

HIGHLIGHTS

 

Resilient Performance Against Global Uncertainty - Strong Second-Half
Performance, Robust Margins, Strong Cash Position, Strengthened Order Book,
and Optimistic Outlook

FINANCIAL HEADLINES

·    Order intake £1.9m (2024: £6.6m)

·    Sales £1.6m (2024: £2.9m)

·    Gross profit margin 58% (2024:53%)

·    Administrative expenses £1.2m (2024: £1.3m)

·    Pre-tax loss £0.3m (2024: profit £0.2m)

·    Year-end order book £4.67m (2024: £4.47m)

·    Year-end cash balance £1.13m (2024: £0.91m)

 

Image Scan's Chief Executive, Vince Deery, commented:

FY25 was a year of contrasts for Image Scan. The first half was marked by
global uncertainty and delayed procurement decisions, which impacted our
revenues and resulted in a loss for the year. However, I am proud of how the
team responded-demonstrating resilience, discipline, and a relentless focus on
operational efficiency.

 

The second half saw a clear turnaround, with improved activity levels, a
return to profitable trading, and a robust closing order book. Our cash
position is strong, and we continue to invest in product innovation and
strategic partnerships to drive future growth.

 

With a healthy pipeline and recent contract wins, we enter FY26 with renewed
confidence. I would like to thank our employees, partners, and shareholders
for their ongoing support as we build on this momentum and look forward to
delivering improved performance in the year ahead.

 

For further information on the Company, please visit: www.ish.co.uk
(http://www.ish.co.uk/)  and for further information on its products, please
visit: www.3dx-ray.com (http://www.3dx-ray.com/)

 

-ENDS-

 

Image Scan Holdings plc
                            Tel: +44 (0) 1509 817400

Vincent Deery CEO

Sarah Atwell-King, CFO & Company Secretary

 

Zeus - Nominated Advisor and Corporate Broker
             Tel: +44 (0)203 829 5000

Mike Coe/James Bavister (Investment Banking)

 

 

ABOUT IMAGE SCAN HOLDINGS PLC

About Image Scan Holdings plc

The core activity of the Group is the manufacture of portable X-ray systems
for security and counter terrorism applications. The Group recently launched a
cabinet X-ray machine and is replacing its Axis range of checkpoint X-ray
systems with new machines developed with a partner. All these products are
taken to market across the world through a strong network of international
partners.

 

In addition, over the last seventeen years, Image Scan has developed and
manufactured industrial X-ray inspection systems, the MDXi range. The primary
market for these systems is in automotive emissions control where they are
used for quality control inspection of catalytic converters and diesel
particulate filters.

 

The visibility and reach of the Company's 3DX-Ray brand has been further
strengthened through a new LinkedIn profile focussed on its EOD and
counter-terrorism activities. This can be found at:
 https://www.linkedin.com/company/3dx-ray/
(https://www.linkedin.com/company/3dx-ray/)
(https://www.linkedin.com/company/3dx-ray/)

 

For further information on the Company, please visit: www.ish.co.uk
(http://www.ish.co.uk/)  - and for further information on its products,
please visit: www.3dx-ray.com (http://www.3dx-ray.com/)

 

CHAIRMAN'S STATEMENT

Overview

For the year ended 30 September 2025 (the "Year"), the Group generated
revenues of £1.6m (2024: £2.9m), and a loss before tax of £0.3m (2024:
profit £0.2m). FY25 was a year of contrasts. The first half presented
significant challenges, driven by global uncertainty surrounding the new U.S.
administration and tariff policies. This hesitation rippled across markets,
delaying government spending and procurement decisions worldwide. Despite
these headwinds, the team demonstrated resilience and discipline, maintaining
tight cost control and operational efficiency. Group cash balances closed at
£1.13m (2024: £0.91m), reinforcing our financial strength.

The second half of the year marked a clear turnaround. Activity levels
improved, profitability strengthened, and we closed the year with renewed
momentum. Our commitment to innovation and market responsiveness remains
steadfast, and we continue to invest in product development and strategic
partnerships to secure long-term growth.

Outlook

With a strengthened order book, a healthy cash position of £1.13 million, and
continued, focused investment in product development, we stand on a solid
operational and financial foundation. The continuing success of our flagship
ThreatScan portable x-ray platform, coupled with encouraging post-year-end
contract awards and a robust pipeline, strongly reinforces our confidence in
our ability to deliver substantial growth and a much-improved performance in
FY26.

 

Leveraging the collective expertise of our team, and with determination and
agility, the Board remains confident in the Group's medium to long-term
prospects. We are fully committed to capitalising on the significant
operational momentum built in the latter part of the year, which is further
reinforced by the subsequent substantial orders notified post year-end.
Alongside this, we are actively pursuing focused strategic and organic
initiatives that will underpin our future growth trajectory.

 

 

Tim Jackson

CHAIRMAN

 

 

 

 

 

CEO REPORT

BUSINESS REVIEW

FY25 began under the shadow of persistent global economic uncertainty.
Concerns around U.S. trade policy and tariffs created hesitation among
government organisations, which resulted in delayed procurement cycles across
our key international markets. As an exporter, with around 90% of our products
going overseas, this environment was particularly challenging, with delays
evident across the Middle East, Southeast Asia, and Europe,

 

Throughout the difficult trading conditions in the first half of the year, the
Group maintained strict cost discipline and organisational efficiency. Our
strategy was focused on proactive engagement and sustaining competitiveness
through ongoing product development. This decisive action resulted in a marked
improvement in demand and profitability in the second half of the year.

 

Continued, focused investment ensured that our flagship ThreatScan® platform
gained further traction, reinforcing our competitive position in international
tenders and deliveries to over twenty territories.

 

We were pleased to announce two significant contract awards in August 25 which
materially strengthened our order book. The first was for a new customer in
North America for our industrial MDXi-400 system a notable achievement given
the maturity of this market. The second was for our latest portable
ThreatScan® system for an Eastern European military organisation.
Additionally, we progressed deliveries of a double-digit quantity of
ThreatScan® systems to a Southeast Asian customer. It must be noted, however,
that supply chain lead times prevented the completion of key contracts, which
limited overall revenue.

 

Our sales team maintained excellent market visibility through participation in
key trade shows and Counter Explosive Ordnance conventions. These efforts
generated new opportunities and supported robust performance in several
geographies, with Europe and Asia delivering particularly strong results, and
India returning to growth.

 

Our operational discipline is reflected in our strengthened financial
position: our cash position improved significantly during the year, reaching
£1.13m at year-end (FY24: £0.91m), a testament to disciplined financial
management and active working capital control.

 

Industrial revenues provided stronger-than-anticipated results, as the
strength of our recurring income from service and software contracts
successfully mitigated the anticipated decline and structural changes in the
catalyst-related business, underscoring the Group's adaptability.

 

We continue to seek clarity on the timing of a major UK defence contract.
While progress has been significantly slower than expected, recent
developments have been positive, though timelines remain dictated by
government processes.

 

OUTLOOK

 

We enter FY26 with renewed confidence following a strong second-half
performance and a significantly strengthened order book. Market activity
levels remain high post-year end, reinforced by recent contract awards,
providing a robust order book and a solid foundation for sustained success.

 

We also note that progress on the large UK defence contract has been slower
than anticipated. While we are seeing recent positive developments, timelines
remain dictated by the pace of government departments, and we continue to work
closely with all stakeholders to advance this important opportunity.

 

Continued investment in product development, particularly the ThreatScan®
platform, positions us well to maintain competitiveness and access new
opportunities. We are committed to reinforcing our global channel network,
prioritising engagement at trade shows and industry events, and actively
exploring strategic alliances, and partnerships, to accelerate future success
and enhance long-term shareholder value. While geopolitical uncertainties
remain, the current momentum and high activity levels give us optimism for the
year ahead.

 

 

Vincent Deery

CHIEF EXECUTIVE OFFICER

 

 

 

 

 

 

 

CFO REPORT

 

KEY PERFORMANCE INDICATORS

                           2025      2024    2023    2022      2021
 Order intake              £1.9m     £6.6m   £2.9m   £2.2m     £2.8m
 Turnover                  £1.6m     £2.9m   £3.0m   £2.0m     £2.9m
 Gross profit margin       58%       53%     48%     54%       53%
 Profit/(loss) before tax  (£0.3m)   £0.2m   £0.1m   (£0.4m)   £0.2m
 Cash balance              £1,131k   £911k   £958k   £690k     £1,186k
 Inventory Balance         £374k     £393k   £349k   £629k     £393k

 

FINANCIAL RESULTS

FY25 was a difficult year for Image Scan, delivering a pre-tax loss of £288k
after two successive years of profit. The stronger second half performance
indicate FY25 was an unusual year largely due the impact of global uncertainty
leading to governments delaying spends. Notably, our gross margin increased to
58%, the highest on record for the Group. The improved closing bank balances
along with the strong order book and underlying opportunity pipeline provides
forward looking metrics which give confidence for FY26.

 

 

Sarah Atwell King

CHIEF FINANCIAL OFFICER

 

 

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the year ended 30 September 2025

 

                                                                            Note

                                                                                      2025         2024

                                                                                      £            £

 REVENUE                                                                              1,617,718    2,860,776
 Cost of sales                                                                        (671,393)    (1,348,975)

 Gross profit                                                                         946,325      1,511,801

 Administrative expenses                                                              (1,238,253)  (1,313,730)
 Other operating income                                                               -            3,474

 OPERATING (LOSS)/PROFIT                                                              (291,928)    201,545

 Finance income                                                                       7,888        10,736
 Interest payable and similar charges                                                 (3,984)      (4,514)

 (LOSS)/PROFIT BEFORE TAXATION                                                        (288,024)    207,767

 Taxation                                                                             -            (756)

 (LOSS)/PROFIT AND TOTAL COMPREHENSIVE INCOME FOR THE YEAR FROM CONTINUING            (288,024)    207,011
 OPERATIONS ATTRIBUTABLE TO THE EQUITY OWNERS OF THE PARENT COMPANY

                                                                                      Pence        Pence
 Earnings per share
 Basic                                                                      2         (0.21)       0.15
 Diluted                                                                              (0.21)       0.15

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 30 September 2025

 

                                                  2025         2024

                                                  £            £
 NON-CURRENT ASSETS
 Intangible assets                                309,733      333,249
 Property, plant and equipment                    -            -
 Right of use asset                               79,893       143,873

                                                  389,626      477,122

 CURRENT ASSETS
 Inventories                                      374,176      392,643
 Trade and other receivables                      422,164      910,775
 Cash and cash equivalents                        1,130,955    911,468

                                                  1,927,295    2,214,886

 TOTAL ASSETS                                     2,316,921    2,692,008

 CURRENT LIABILITIES
 Trade and other payables                         776,852      792,167
 Lease liability                                  48,467       53,158
 Warranty provision                               15,522       25,473

                                                  840,841      870,798

 NON-CURRENT LIABILITIES
 Lease liability                                  45,392       102,498

                                                  45,392       102,498

 NET ASSETS                                       1,430,688    1,718,712

 EQUITY
 Share capital                                    1,368,546    1,368,546
 Share premium account                            8,332,910    8,332,910
 Profit and loss account                          (8,270,768)  (7,982,744)

 TOTAL EQUITY ATTRIBUTABLE TO SHAREHOLDERS        1,430,688    1,718,712

 

 

 

STATEMENT OF CHANGES IN EQUITY

For the year ended 30 September 2025

 

 CONSOLIDATED                                                              Share capital  Share premium  Profit and loss account

                                                                           £              £              £                        Total

                                                                                                                                  £
 As at 1 October 2023                                                      1,368,546      8,332,910      (8,189,755)              1,511,701

 Profit for the year and total comprehensive income for the year           -              -              207,011                  207,011

 As at 30 September 2024                                                   1,368,546      8,332,910      (7,982,744)              1,718,712

 Loss for the year and total comprehensive income for the year             -              -              (288,024)                (288,024)

 As at 30 September 2025                                                   1,368,546      8,332,910      (8,270,768)              1,430,688

 

 

 

CONSOLIDATED CASH FLOW STATEMENT

Year ended 30 September 2025

 

                                                                                                     2025       2024

                                                                                                     £          £
 Cash flows from operating activities
 Operating (loss)/profit                                                                             (291,928)  201,545

 Adjustments for:
 Amortisation of intangible assets                                                                   66,394     62,350
 Depreciation                                                                                        -          7,199
 Amortisation of right of use asset                                                                  45,584     40,524
 Research and development expenditure credit                                                         -          (3,474)
 Increase/(decrease) in impairment of inventories                                                    31,838     (9,280)
 Increase in inventories                                                                             (13,371)   (34,610)
 Decrease/(increase) in trade and other receivables                                                  488,611    (300,627)
 Decrease/(increase) in trade and other payables                                                     (15,315)   79,712
 Decrease in warranty provisions                                                                     (9,951)    (8,385)

 Cash generated from operating activities                                                            301,862    34,954
 Corporation tax received                                                                            -          26,440

 Net cash flows generated from operating activities                                                  301,862    61,394

 Cash flows from investing activities
 Interest received                                                                                   7,888      10,736
 Purchase of intangibles                                                                             (42,878)   (74,642)
 Purchase of property, plant and equipment                                                           -          (600)

 Net cash used in investing activities                                                               (34,990)   (64,506)

 CASH FLOWS FROM FINANCING ACTIVITIES
 Lease payments (capital and interest)                                                               (47,385)   (43,885)

 Net cash used in financing activities                                                               (47,385)   (43,885)

 Net INCREASE(DECREASE) in cash and cash equivalents                                                 219,487    (46,997)
 Cash and cash equivalents at beginning of year                                                      911,468    958,465

 Cash and cash equivalents at end of year                                                            1,130,955  911,468

 

 

 

 

Notes to this statement

1. Basis of preparation

While the financial information included in this annual financial results
announcement has been prepared in accordance with the recognition and
measurement principles of UK adopted international accounting standards, this
announcement does not contain sufficient information to comply therewith.

 

The financial information set out above does not constitute the Group's
statutory accounts for the years ended 30 September 2025 or 30 September 2024
but is derived from those accounts. Statutory accounts for 2024 have been
delivered to the Registrar of Companies, and those for 2025 will be delivered
following the Company's Annual General Meeting. The auditors have reported on
those accounts; their reports were unqualified and did not contain statements
under Section 498 of the Companies Act 2006.

 

2.    Earnings per share

The diluted earnings per share is calculated by adjusting the weighted average
number of ordinary shares in issue on the assumption of conversion of dilutive
potential ordinary shares.  The Company's dilutive potential ordinary shares
are shares issued under the Company's Enterprise Management Incentive ('EMI')
scheme and options issued under the Company's Unapproved scheme. Where the
Company is reporting losses, the impact of share options is
considered anti-dilutive.  Where the Company is reporting profits, share
options could potentially dilute basic earnings per share in the future but
are only included in the calculation of diluted earnings per share when the
exercise price of the share options is below the average share price in the
year.

 

                                                                  2025         2024

                                                                  £            £

 (Loss)/profit for the year                                       (288,024)    207,011

 Weighted average number of ordinary shares in issue              136,854,577  136,854,577
 Number of diluted shares                                         136,854,577  136,854,577

 Basic (loss)/profit per share                                    (0.21p)      0.15p
 Diluted (loss)/profit per share                                  (0.21p)      0.15p

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FR PKDBQOBDDQBK



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Image Scan Holdings

See all news